1-4 of 4
Jill K. Fisher
Close
Sort by
Journal Articles

Mantle cell lymphoma in cyclin D1 transgenic mice with Bim -deficient B cells

Samuel G. Katz, James L. LaBelle, Hailong Meng, Regina P. Valeriano, Jill K. Fisher, Heather Sun, Scott J. Rodig, Steven H. Kleinstein, Loren D. Walensky
Journal: Blood
Blood (2014) 123 (6): 884–893.
https://doi.org/10.1182/blood-2013-04-499079
Published: 2014
Includes: Supplemental data
Journal Articles

Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function

Desiree A. Steimer, Kelli Boyd, Osamu Takeuchi, Jill K. Fisher, Gerard P. Zambetti, Joseph T. Opferman
Journal: Blood
Blood (2009) 113 (12): 2805–2815.
https://doi.org/10.1182/blood-2008-05-159145
Published: 2009
Includes: Supplemental data
Journal Articles

Pharmacologic Replacement of BIM BH3 Reactivates Apoptosis in Hematologic Cancer and Lymphoproliferative Disease.

James L. LaBelle, MD, PhD, Jill K. Fisher, Samuel G. Katz, MD, PhD, Gregory H. Bird, PhD, Chelsea E. Lawrence, Amy M. Silverstein, Loren D. Walensky, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 524.
https://doi.org/10.1182/blood.V110.11.524.524
Published: 2007
Journal Articles

Proteolysis of MLL Family Proteins Is Essential for Taspase1−Orchestrated Cell Cycle Progression.

James J. Hsieh, Shugaku Takeda, David Y. Chen, Todd D. Westergard, Jill K. Fisher, Jeffrey A. Rubens, Satoru Sasagawa, Jason T. Kan, Stanley J. Korsmeyer, Emily H. Cheng
Journal: Blood
Blood (2006) 108 (11): 769.
https://doi.org/10.1182/blood.V108.11.769.769
Published: 2006